Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123094) titled 'Molecular Biological and Clinical Study of Faricimab in Treatment-Naive Patients with Different Types of Diabetic Macular Edema' on April 21.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Hebei Eye Hospital
Condition:
Diabetic Macular Edema
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-30
Target Sample Size: Observation group:100;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=318001
Disclaimer: Curated by HT Syndication....